you're reading...
Economic and Social Policies, PUBLICATIONS

Ten technologies to fight Covid-19

Written by Mihalis Kritikos,

© Shutterstock

As the coronavirus (Covid-19) pandemic intensifies, technological applications and initiatives are multiplying in an attempt to limit the spread of the disease, treat patients and facilitate the work of overworked healthcare workers. At a time when everyone needs better information, including epidemic disease modellers, state authorities, international organisations and people in quarantine, measures such as social distancing, and digital information and surveillance technologies have been unleashed in an unprecedented manner to collect data and reliable evidence in support of public health decision-making.

Countries around the world are authorising clinical trials involving experimental techniques such as gene editing, synthetic biology and nanotechnologies, in a race to prepare and testing future vaccines, treatments and diagnostics. Artificial intelligence, robots and drones are helping to track the disease and enforce restrictive measures while service robots are being deployed in various ways in hospitals.

Bottom-up technologies, such as 3D printing and open-software solutions are being harnessed to address the growing need for medical hardware (e.g. masks, ventilators and breathing filters) and optimise the supply of the necessary medical equipment to hospitals. Blockchain applications can meanwhile track contagion, manage insurance payments related to the disease outbreak, sustain medical supply chains and facilitate the performance of much-needed EU-wide clinical trials in an effective, transparent and credible manner.

At the same time, throughout this pandemic crisis, telehealth technologies have emerged as a cost-effective means to slow the virus’s spread and to maintain hospital capacity, by operating as a triage system, keeping those with moderate symptoms at home and routing more severe cases to hospitals.

But are these technologies safe and effective in the context of Covid-19? Have they been tested before in a public health emergency context? Are they ready to provide tangible and operative solutions that could facilitate governments’ efforts to address the many challenges associated with this pandemic? Do they strengthen the evidence-based character of the response measures taken worldwide? Can possible regulatory hurdles concerning their authorisation be by-passed via ad hoc fast-track procedures? Does their extensive or immediate use involve risks and threaten our values and rights in the long run?

EPRS in-depth analysis

This well-timed EPRS publication on the ten technologies central to the fight against Covid-19 offers some well-informed answers to these crucial questions. More importantly, it constitutes a much-needed analysis of what is at stake, amid the Covid-19 pandemic, in technological terms world-wide, paying particular attention to applications that have either been put in use or are being tested before operational deployment.

The analysis presents a non-exhaustive overview of the technologies currently in use, highlighting their main features and significance in the response to the coronavirus pandemic but also their possible limitations. It examines a wide range of technological applications developed to monitor and contain the rapid spread of the disease but also to ensure that public health institutions maintain their capacity to meet the ever-increasing needs generated by the pandemic.

However, given that most of these technological applications have been mainstreamed or put forward in a hasty decision-making environment where decisions are extremely reactive, careful thought must also be given to their potential repercussions. In the context of the current pandemic, governments have launched numerous data-collection and location-tracking technological applications by means of emergency laws that involve the temporary suspension of fundamental rights, triggering questions about the potential future impact on hard-won civil liberties and concerns about state authorities maintaining heightened levels of surveillance even after the pandemic has ended. Medical devices and in-vitro diagnostics vaccines are meanwhile in the pipeline for fast-tracked authorisation although most of these technologies have never been applied in a medical emergency context before. Furthermore, all this also raises the question of whether the fight against Covid-19 will facilitate even more aggressive automation of daily life when everything returns to ‘normal’.

The analysis addresses the possible lasting legal and ethical questions that policy-makers, legislators and expert groups that advise governments and international organisations and will be confronted with very soon and brings forward some preliminary considerations. It illustrates the main regulatory and socio-ethical dilemmas that the manifold use of these technologies poses when used in a public-health emergency context such as the current one but also those that will arise once the virus has subsided. The analysis identifies the legal challenges that emerging technologies, such as those currently employed in the context of Covid-19 pose to existing EU legislation, examines possible legal gaps and proposes options for the emergency authorisation of some of the technological applications under consideration.

Although the focus of this analysis is on technological applications presenting solutions to pressing pandemic-related problems, this piece of work does not aim to reinforce ideas of techno-solutionism. In other words, technological applications in their own right cannot solve complex societal challenges, such as those associated with the current pandemic. Rather, the main findings of the analysis indicate that technology cannot in itself replace or make up for other public policy measures but it does have an increasingly critical role to play in emergency responses in a variety of domains.

The current crisis has demonstrated not only the vulnerability of global public health systems but also the potential of certain emerging technological pathways to fight this pandemic disease at the levels of prevention, containment and treatment. The first major pandemic of our century, Covid-19 represents an excellent opportunity for policy-makers and regulators to reflect on the legal plausibility, ethical soundness and effectiveness of deploying emerging technologies under extreme time pressure. Striking the right balance will be crucial when it comes to maintaining the public’s trust in evidence-based public health interventions and for safeguarding the potential of promising – albeit immature – technologies to serve the public interest.


Read the complete ‘in-depth analysis’ on ‘Ten technologies to fight coronavirus‘ in the Think Tank pages of the European Parliament.

About Scientific Foresight (STOA)

The Scientific Foresight Unit (STOA) carries out interdisciplinary research and provides strategic advice in the field of science and technology options assessment and scientific foresight. It undertakes in-depth studies and organises workshops on developments in these fields, and it hosts the European Science-Media Hub (ESMH), a platform to promote networking, training and knowledge sharing between the EP, the scientific community and the media. All this work is carried out under the guidance of the Panel for the Future of Science and Technology (STOA), composed of 27 MEPs nominated by 11 EP Committees. The STOA Panel forms an integral part of the structure of the EP.

Discussion

2 thoughts on “Ten technologies to fight Covid-19

  1. People are not understanding the COVID paradox

    In the USA,the exposed cases are at least 20 times the number of the current detected cases,of 3.5 million,AND THE ACTUAL INFECTED CASES ARE AT LEAST,1O TIMES the current detected cases.

    The current daily count in the USA is around 70000 and was around 25-30,000,a fortnught ago.These incremental 35000 were EXPOSED around 27 days ago (at the earliest) and were INFECTED ENOUGH,to take a TEST.

    Therefore,it is safe to assume that for every 70000 cases today there are at least 70000 more INFECTED BUT NOT WITH SUFFICIENT SYMPTOMS TODAY plus some more WHO DO NOT WANT TO GET TESTED AT ALL.

    Further,for every 1 COVID positive person WITH SYMPTOMS – it is safe to assume an EXPOSURE RATIO OF 10:1 IN A SPAM OF 30 DAYS – starting from the time when the COVID +ve person was 1st EXPOSED.

    So for the 70000 cases today, there are AT LEAST 70000 more COVID positive person (based on 1 day’s data),which makes it 140000.These people have exposed at least 1.4 million in the last 30 days !

    So,if you look at the number of cases in the USA in the last 30 days at 30000 a day,so you have a ROLLING stock of 6 million EXPOSURES just in 30 days – who will show symptoms in the next 7-30 days,and so the numbers will skyrocket.

    Based on a population of 350 million – IT IS ONLY WHEN THE USA has 17-20 million DETECTED CASES – that the COVID saga will end.There WILL be NO CURE,AND NO VACCINE – just trial and error diagnostics.

    So we are a long way away.dindooohindoo

    30 days ago,the USA COVID cases were around 1.5 million and so the EXPOSURES were at 30 million.From that 30 million – in the last 30 days – the USA has had around 35000 cases per day,in the last 30 days – which is around 3% of the EXPOSURES,as of 30 days ago.

    The Rolling stock as above,WILL DOUBLE IN A MINIMUM OF 30 DAYS and the 3% will also DOUBLE IN EVERY 60 DAYS at the minimum.These are the coordinates of doom.

    There is NO STATISTIC on 1 PARAMETER.How many COVID discharged humans in the USA were re-infected,and in what duration ? That is the ONLY HOPE – id.est., to be infected and survive.Can it REALLY BE ZERO ? Or does it show THAT releasing a COVID cured patient into the jungle – is the biggest disaster – a ticking neutron bomb ?

    USA numbers look devastating,as they have the infra,to test on that scale.The situation in other parts of the world is BEYOND redemption.

    Even in the USA,the sharp rise in Cases,is NOT DUE to the re-opening of businesses – BIT DUE TO LACK OF TESTING.It is the people who WERE NOT TESTED,in the last 30 days,AND HAD synptoms – which is reflecting in the current data,of 70000 a day.

    You can imagine the CATASTROPHIC DOOM,in Brazil and India – where THEY WILL NEVER be able to test,on the American scale.

    In essence,the entire population of 7 billion,HAS TO BE infected,and at least 10%,will die due to COVID,and 10% more will die,due to other morbidities,which will have no medical attention and another 10%,will die due to starvation.

    The persons who will die,are those,with a weak and infirm constitution,and low natural immunity – and whose body,is already damaged by medicines,steroids,nicotine,cocaine,adulterated food and alcohol.

    A Perfect Constitution,is an essential,for a Perfect Brain

    This is the Greek Formula,updated for AI + Robotics + Nanotech

    The Greeks used to discard their defective samples,at BIRTH,on Mt Olmypus,for the ravens and vultures.That was he Priori Best Practice.2000 years since then, AI + Robotics + Nanotech, has made Humans obsolete.

    Thence,comes in COVID – just like Pure Providence.After the 10+10+10% culling – we will get the NEXT virus – which will be in action,by November 2021.That virus will target,in Phase 1,the clowns CURED BY COVID – as the COVID bird has laid its nest in them.Then it will target those who were infected by COVID but did not show the symptoms.

    Like a never ending Geometric Progression – towards redemption and salvation,like Zeno’s Paradox.

    Like

    Posted by samir sardana | July 13, 2020, 00:42

Trackbacks/Pingbacks

  1. Pingback: Ten technologies to fight Covid-19 | Vatcompany.net - April 23, 2020

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,313 other followers

RSS Link to Scientific Foresight (STOA)

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.

%d bloggers like this: